Terminated NA INTERVENTIONAL 2-arm NCT00145704

Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density

Treatment of Childhood Cancer Therapy-induced Osteopenia in Growth Hormone Deficient Adult Survivors: Does Bisphosphonate Treatment Improve Bone Mineral Density?

Sponsor: Genentech, Inc.

Conditions Osteopenia

Interventions Calcium Vitamin D supplement bisphosphonate therapy (risedronate)

Updated 8 times since 2017 Last updated: Mar 1, 2013 Started: Jun 30, 2002 Primary completion: Oct 31, 2008 Completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

due to low enrollment, participants are no longer being examined or treated

Other terminated trials from Genentech, Inc.

More terminations from Genentech, Inc.

Other Osteopenia trials with similar outcome

Browse all Osteopenia trials

This NA trial investigates Osteopenia and is currently terminated or withdrawn. Genentech, Inc. leads this study, which shows 8 recorded versions since 2002 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2023 — Jul 2024 [monthly]

Terminated NA
Dec 2022 — Jan 2023 [monthly]

Terminated NA
Dec 2021 — Dec 2022 [monthly]

Terminated NA

▶ Show 3 earlier versions

Jan 2021 — Dec 2021 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Jun 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Genentech, Inc.
State University of New York - Upstate Medical University

Data source: State University of New York - Upstate Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Syracuse, United States